AU Stock MarketDetailed Quotes

IXC Invex Therapeutics Ltd

Watchlist
  • 0.076
  • 0.0000.00%
20min DelayMarket Closed Nov 21 13:27 AET
5.71MMarket Cap-3454P/E (Static)

Invex Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(FY)Jun 30, 2023
(FY)Jun 30, 2022
(FY)Jun 30, 2021
(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities
164.06%1.21M
151.90%459.09K
182.25K
Income from government grants
--1.21M
----
----
----
----
Other cash income from operating activities
----
151.90%459.09K
--182.25K
----
----
Cash paid
48.95%-4.15M
-123.29%-8.13M
-98.08%-3.64M
-3.84%-1.84M
-1.77M
Payments to suppliers for goods and services
48.95%-4.15M
-123.29%-8.13M
-98.08%-3.64M
-3.84%-1.84M
---1.77M
Direct interest received
-38.30%491.82K
897.84%797.08K
-49.69%79.88K
-4.17%158.79K
--165.7K
Operating cash flow
64.42%-2.44M
-103.43%-6.87M
-101.20%-3.38M
-4.67%-1.68M
---1.6M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-14M
-48.56%8.09M
15.73M
Net common stock issuance
---14M
----
----
-43.91%8.09M
--14.43M
Net other financing activities
----
----
----
----
--1.3M
Cash from discontinued financing activities
Financing cash flow
---14M
----
----
-48.56%8.09M
--15.73M
Net cash flow
Beginning cash position
-23.41%22.47M
-10.32%29.34M
24.39%32.72M
116.10%26.3M
--12.17M
Current changes in cash
-139.41%-16.45M
-103.43%-6.87M
-152.63%-3.38M
-54.60%6.42M
--14.13M
End cash Position
-73.19%6.03M
-23.41%22.47M
-10.32%29.34M
24.39%32.72M
--26.3M
Free cash from
64.42%-2.44M
-103.43%-6.87M
-101.20%-3.38M
-4.67%-1.68M
---1.6M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2024(FY)Jun 30, 2023(FY)Jun 30, 2022(FY)Jun 30, 2021(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities 164.06%1.21M151.90%459.09K182.25K
Income from government grants --1.21M----------------
Other cash income from operating activities ----151.90%459.09K--182.25K--------
Cash paid 48.95%-4.15M-123.29%-8.13M-98.08%-3.64M-3.84%-1.84M-1.77M
Payments to suppliers for goods and services 48.95%-4.15M-123.29%-8.13M-98.08%-3.64M-3.84%-1.84M---1.77M
Direct interest received -38.30%491.82K897.84%797.08K-49.69%79.88K-4.17%158.79K--165.7K
Operating cash flow 64.42%-2.44M-103.43%-6.87M-101.20%-3.38M-4.67%-1.68M---1.6M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -14M-48.56%8.09M15.73M
Net common stock issuance ---14M---------43.91%8.09M--14.43M
Net other financing activities ------------------1.3M
Cash from discontinued financing activities
Financing cash flow ---14M---------48.56%8.09M--15.73M
Net cash flow
Beginning cash position -23.41%22.47M-10.32%29.34M24.39%32.72M116.10%26.3M--12.17M
Current changes in cash -139.41%-16.45M-103.43%-6.87M-152.63%-3.38M-54.60%6.42M--14.13M
End cash Position -73.19%6.03M-23.41%22.47M-10.32%29.34M24.39%32.72M--26.3M
Free cash from 64.42%-2.44M-103.43%-6.87M-101.20%-3.38M-4.67%-1.68M---1.6M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg

No Data